Using artificial intelligence to identify anti-hypertensives as possible disease modifying agents in Parkinson's disease.

Naomi P VisanjiPiyush MadanAlix M B LacosteItalo BulejeYanyan HanScott SpanglerLorraine V KaliaSharon Hensley AlfordConnie Marras

Published in: Pharmacoepidemiology and drug safety (2020)

We present evidence that a computational approach can efficiently identify leads for disease-modifying drugs. We have identified the combination of ARBs and DHP-CCBs as of particular interest in PD.

Keyphrases

artificial intelligence
machine learning
big data
deep learning
drug induced